IceCure Medical
ICCM
8 hedge funds and large institutions have $88.5K invested in IceCure Medical in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
0.01% less ownership
Funds ownership: 0.01% → 0.01% (-0.01%)
20% less funds holding
Funds holding: 10 → 8 (-2)
64% less capital invested
Capital invested by funds: $245K → $88.5K (-$156K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
+$632 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$34.4K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$33.8K |
| 3 |
VF
Virtu Financial
New York
|
-$23K |
| 4 |
JP Morgan Chase
New York
|
-$11.7K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$4.81K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BFM
1
Boothbay Fund Management
New York
| $46K | – | – | – |
|
|
2
Bank of America
Charlotte,
North Carolina
| $31.7K | -$34.4K | -926 | -50% |
|
|
3
Osaic Holdings
Scottsdale,
Arizona
| $6.52K | +$632 | +17 | +10% |
|
|
4
UBS Group
Zurich,
Switzerland
| $1.99K | -$33.8K | -908 | -94% |
|
|
5
JP Morgan Chase
New York
| $1K | -$11.7K | -315 | -95% |
|
6
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
|
BCWM
7
Bartlett & Co Wealth Management
Cincinnati,
Ohio
| $287 | – | – | – |
|
|
VF
8
Virtu Financial
New York
| – | -$23K | -487 | Closed |
|
|
9
Wells Fargo
San Francisco,
California
| – | -$4.81K | -106 | Closed |
|
ICCM Hedge Fund Activity: Q1 2023 in Review
8 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in IceCure Medical (ICCM) for Q1 2023, worth a combined $88.5K — down 64% from $245K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ICCM and 0 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 1 added.
The largest buyer was Osaic Holdings, adding an estimated $632. The largest seller was Bank of America, cutting an estimated $34.4K.
- 8 institutional investors held IceCure Medical (ICCM) as of Q1 2023, down from 10 in Q4 2022.
- Funds reported $88.5K of IceCure Medical stock for Q1 2023, down 64% quarter-over-quarter.
- 0 funds opened new IceCure Medical positions in Q1 2023 and 2 closed out, a net change of -2 holders.
- The largest IceCure Medical buyer in Q1 2023 was Osaic Holdings, an estimated $632 added.
- The largest IceCure Medical seller in Q1 2023 was Bank of America, an estimated $34.4K sold.
Based on aggregated 13F filings for Q1 2023.